BIT225, AN HCV-P7 INHIBITOR, WITH ENHANCED ANTI-HCV ACTIVITY IN COMBINATION WITH PEGYLATED INTERFERON-alfa-2b AND RIBAVIRIN IN HCV GENOTYPE-1 TREATMENT NAIVE SUBJECTS: PHARMACOKINETIC AND RESISTANCE STUDIES
Journal of Hepatology（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要